CLEW Medical vs Luminare (2026)
Both address clinical deterioration in hospitals, and they start from opposite premises. CLEW Medical sells FDA cleared machine learning models that predict deterioration in critical care, with operating characteristics stated in its 510(k) summaries; its clearance covers adult critical care, and a 2024 company release put the cleared label on medical and surgical floors. Luminare argues that prediction is not the bottleneck and sells sepsis screening and intervention software built around the clinical response. Its screening rests on established SIRS criteria rather than a learned model, though it describes itself as artificial intelligence. Choose CLEW for cleared prediction in the ICU; choose Luminare if your gap is acting on sepsis alerts rather than raising them.
- Your use is adult critical care or tele ICU.
- You want a learned model with operating characteristics in its 510(k) summary.
- Alarm burden published in a peer reviewed journal matters to your committee.
- Your gap is responding to sepsis alerts, not generating them.
- Screening should lead straight into an intervention workflow.
- You are comfortable with established criteria rather than a learned model.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. CLEW Medical and Luminare are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | CLEW Medical | Luminare |
|---|---|---|
| Primary category | Inpatient Deterioration & Risk Monitoring | Inpatient Deterioration & Risk Monitoring |
| Founded | Not recorded | 2014 |
| Headquarters | Netanya, Israel | Houston, Texas, United States |
| Website | clewmed.com | luminare.io |
Side by Side
Select any grade to read the note behind it.
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
CLEW Medical, based in Netanya, Israel, with US operations in Boston, sells FDA cleared machine learning models that predict clinical deterioration in hospital critical care, delivered through a clinical surveillance platform for bedside and tele-ICU teams. Its operating characteristics are public because the models are regulated as medical devices and the 510(k) summaries state them.
Source: AI Health Index, September 2026
Luminare sells inpatient sepsis screening and intervention software, and its founding argument is that better prediction is not the problem. The company's position, stated on its own site and argued in a peer reviewed review article co authored by its chief executive, is that the health technology industry has concentrated on speed of detection while outcomes stall because clinical staff frequently fail to act on the alert.
Source: AI Health Index, September 2026
Questions buyers ask
How much do CLEW Medical and Luminare leave to the clinician?
CLEWHI flags patients likely to need vasopressor or inotrope support within eight hours; CLEWLR labels patients as low risk of deterioration, a label a unit may lean on when deciding who can step down.
Luminare requires the nurse's assessment as part of the screen, so the system cannot produce an output that a clinician passively ignores. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Inpatient Deterioration & Risk Monitoring page.
Neither vendor's site could be read at review, so both records rest partly on earlier reads and outside sources. Neither publishes a price. Luminare's page runs from a 30 to 50 percent sepsis mortality rate to lives saved without citing a study of its own product.
Ask CLEW which of your units its clearance covers, and ask Luminare which study supports its outcome claims.